申请人:Cassella Aktiengesellschaft
公开号:US05120732A1
公开(公告)日:1992-06-09
Substituted 3-aminosydnone imines of the formula I ##STR1## and their pharmacologically acceptable acid addition salts, in which A denotes, for example, --CH.sub.2 --, R.sup.1 denotes hydrogen or the radical --COR.sup.5, R.sup.2, R.sup.3 denote alkyl having 1 to 4 C atoms, R.sup.5 denotes, for example, an aliphatic radical having 1 to 4 C atoms, and methods for preparing such compounds by cyclization of a compound of the formula II ##STR2## and if desired subsequent acylation. The invention also includes formulations containing effective amounts of such compounds, and methods for administering same to patients for the control and prophylaxis of cardiovascular disorders.
公式I中的化合物为3-氨基亚硝基亚胺,其药物学上可接受的酸盐,其中A代表例如--CH.sub.2 --,R.sup.1代表氢或基团--COR.sup.5,R.sup.2,R.sup.3代表具有1至4个C原子的烷基,R.sup.5代表例如具有1至4个C原子的脂肪基,以及通过化合物II的环化和必要时的酰化制备这种化合物的方法。该发明还包括含有这种化合物有效量的制剂,以及将其用于控制和预防心血管疾病的患者的方法。